Published in Neuropharmacology on August 01, 1987
Anaesthetic suppression of transmitter actions in neocortex. Br J Pharmacol (1990) 0.83
Influence of sulfhydryl reagents and heavy metals on the functional state of the muscarinic acetylcholine receptor in rat brain. Mol Pharmacol (1978) 1.33
Production of 2-phenethyl alcohol and 2-phenyllactic acid in Candida species. Biochem Biophys Res Commun (1974) 1.31
Activation, inactivation, and desensitization of acetylcholine receptor channel complex detected by binding of perhydrohistrionicotoxin. Proc Natl Acad Sci U S A (1980) 1.28
Phencyclidine interactions with the ionic channel of the acetylcholine receptor and electrogenic membrane. Proc Natl Acad Sci U S A (1980) 1.11
Quantitation of striatal and extrastriatal D-2 dopamine receptors using PET imaging of [(18)F]fallypride in nonhuman primates. Synapse (2000) 1.09
Sites of action of phencyclidine. II. Interaction with the ionic channel of the nicotinic receptor. Mol Pharmacol (1980) 1.09
Selective blockade of NMDA-activated channel currents may be implicated in learning deficits caused by lead. FEBS Lett (1990) 1.07
The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels. J Pharmacol Exp Ther (1990) 1.03
M3 muscarinic acetylcholine receptors regulate cytoplasmic myosin by a process involving RhoA and requiring conventional protein kinase C isoforms. J Biol Chem (1999) 1.01
Beta-indoleethanol and beta-indolelactic acid production by Candida species: their antibacterial and autoantibiotic action. Antimicrob Agents Chemother (1976) 1.00
Evaluation of dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride. Neuropsychopharmacology (2001) 0.97
Electrophysiological and biochemical studies on enhancement of desensitization by phenothiazine neuroleptics. Proc Natl Acad Sci U S A (1983) 0.96
[3H]Phencyclidine: a probe for the ionic channel of the nicotinic receptor. Proc Natl Acad Sci U S A (1980) 0.94
Inhibition of neuronal 5-HT uptake by ketamine, but not halothane, involves disruption of substrate recognition by the transporter. Neurosci Lett (1990) 0.94
Production of beta-(4-hydroxyphenyl)ethanol and beta-(4-hydroxyphenyl)lactic acid by Candida species. Can J Microbiol (1976) 0.93
Pharyngeal cysts. J Indian Med Assoc (1977) 0.92
Volatile anesthetics and glutamate activation of N-methyl-D-aspartate receptors. Biochem Pharmacol (1995) 0.92
Conversion between configurational states of the muscarinic receptor in rat brain. Eur J Pharmacol (1977) 0.91
Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors. Mol Pharmacol (1989) 0.91
The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties. Mol Pharmacol (1984) 0.90
Structural and stereochemical requirements for muscarinic receptor binding. Mol Pharmacol (1979) 0.90
Sites of action of phencyclidine. I. Effects on the electrical excitability and chemosensitive properties of the neuromuscular junction of skeletal muscle. Mol Pharmacol (1980) 0.90
Similarities in the binding sites of the muscarinic receptor and the ionic channel of the nicotinic receptor. Biochem Pharmacol (1980) 0.90
5,8-disubstituted indolizidines: a new class of noncompetitive blockers for nicotinic receptor-channels. Neurochem Res (1991) 0.89
Nature of regional and chemically-induced differences in the binding properties of muscarinic acetylcholine receptors from rat brain. Neuropharmacology (1980) 0.89
Sites of action of phencyclidine. III. Interactions with muscarinic receptors. Mol Pharmacol (1980) 0.89
Solubilization of muscarinic acetylcholine receptors of bovine brain. Life Sci (1978) 0.89
Clonidine protection from the toxicity of soman, an organophosphate acetylcholinesterase inhibitor, in the mouse. J Pharmacol Exp Ther (1986) 0.87
Acute effects of a bicyclophosphate neuroconvulsant on monoamine neurotransmitter and metabolite levels in the rat brain. J Toxicol Environ Health A (1998) 0.87
Interaction of gephyrotoxin and indolizidine alkaloids with the nicotinic acetylcholine receptor-ion channel complex of Torpedo electroplax. Neurochem Res (1986) 0.86
Effects of adenosine and analogs on adenylate cyclase activity in cultured bovine aortic endothelial cells. Biochem Pharmacol (1990) 0.85
Cholinergic supersensitivity and decreased number of muscarinic receptors in atria from short-term diabetic rats. J Mol Cell Cardiol (1984) 0.85
Ketamine inhibition of ligand binding to cholinergic receptors and ion channels. Eur J Pharmacol (1982) 0.84
Development of muscarinic cholinergic receptors in inbred strains of mice: identification of receptor heterogeneity and relation to audiogenic seizure susceptibility. Brain Res (1979) 0.84
Muscarinic cholinergic binding in human erythrocyte membranes. Life Sci (1977) 0.84
Changes in cholinergic parameters associated with failure of conotruncal septation in embryonic chick hearts after neural crest ablation. Circ Res (1985) 0.84
Regulation of [3H]perhydrohistrionicotoxin binding to Torpedo ocellata electroplax by effectors of the acetylcholine receptor. J Biol Chem (1981) 0.84
Influence of N-ethylmaleimide on cholinoceptors and responses in longitudinal muscles from guinea-pig ileum. Br J Pharmacol (1982) 0.84
Clonidine protection from soman and echothiophate toxicity in mice. Life Sci (1986) 0.84
Involvement of protein kinase C and protein kinase A in the muscarinic receptor signalling pathways mediating phospholipase C activation, arachidonic acid release and calcium mobilisation. Cell Signal (1999) 0.83
Temperature effect on the detection of muscarinic receptor-G protein interactions in ligand binding assays. Biochem Pharmacol (1988) 0.82
Increased muscarinic responsiveness and decreased muscarinic receptor content in ileal smooth muscle in diabetes. J Pharmacol Exp Ther (1990) 0.82
Allosteric effect of gallamine on muscarinic cholinergic receptor binding: influence of guanine nucleotides and conformational state. Neurochem Res (1986) 0.82
Decahydroquinoline alkaloids: noncompetitive blockers for nicotinic acetylcholine receptor-channels in pheochromocytoma cells and Torpedo electroplax. Neurochem Res (1991) 0.82
Disruption of muscarinic receptor-G protein coupling is a general property of liquid volatile anesthetics. Neurosci Lett (1989) 0.82
Interactions of tricyclic antidepressants with a synaptic ion channel. Life Sci (1981) 0.81
Effect of colchicine and taxol on stimulation of G protein GTPase activity in anterior pituitary lobe of rats by gonadotrophin- and thyrotrophin-releasing hormones. J Reprod Fertil (1993) 0.81
Interactions of bupivacaine with ionic channels of the nicotinic receptor. Electrophysiological and biochemical studies. Mol Pharmacol (1984) 0.80
Interactions of microtubule-active agents with nicotinic acetylcholine receptors. Relationship to their inhibition of catecholamine secretion by adrenal chromaffin cells. Mol Pharmacol (1985) 0.80
A novel agonist binding site on nicotinic acetylcholine receptors. J Recept Res (1993) 0.79
Altered muscarinic receptor properties and function in the heart in diabetes. J Pharmacol Exp Ther (1987) 0.79
Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites. J Pharmacol Exp Ther (1991) 0.79
Pyrazole, an alcohol dehydrogenase inhibitor, has dual effects on N-methyl-D-aspartate receptors of hippocampal pyramidal cells: agonist and noncompetitive antagonist. J Pharmacol Exp Ther (1992) 0.79
Reversible conversion between affinity states for agonists of the muscarinic acetylcholine receptor from rat brain. Biochem Pharmacol (1979) 0.79
Adrenergic agonists protect against soman, an irreversible acetylcholinesterase inhibitor. Toxicol Lett (1987) 0.78
Benzomorphan interactions with acetylcholine receptor complexes from Torpedo. Eur J Pharmacol (1983) 0.78
Precursors of cholinergic false transmitters: central effects on blood pressure and direct interactions with cholinergic receptors. Neuropharmacology (1988) 0.78
Biosynthesis of beta-phenethyl alcohol in Candida guilliermondii. Biochem Biophys Res Commun (1976) 0.78
In vitro and in vivo evaluation of the binding of the dopamine D2 receptor agonist (11)C-(R,S)-5-hydroxy-2-(di-n-propylamino)tetralin in rodents and nonhuman primate. Synapse (2000) 0.78
Radiosynthesis and in vitro evaluation of 2-(N-alkyl-N-1'-11C-propyl)amino-5-hydroxytetralin analogs as high affinity agonists for dopamine D-2 receptors. Nucl Med Biol (1999) 0.77
Characterization of the muscarinic receptor subtypes in the bovine corneal epithelial cells. J Ocul Pharmacol Ther (1996) 0.77
Role of central biogenic amines on the protection afforded by clonidine against the toxicity of soman, an irreversible cholinesterase inhibitor. Toxicol Lett (1988) 0.77
Retinoic acid-induced differentiation of a human neuroblastoma cell line alters muscarinic receptor expression. Brain Res Dev Brain Res (1993) 0.77
Modulation of adenylate cyclase activity in cultured bovine pulmonary arterial endothelial cells. Effects of adenosine and derivatives. Biochem Pharmacol (1989) 0.77
Substance P receptor desensitization in the dorsal horn: possible involvement of receptor-G protein complexes. Brain Res (1993) 0.77
Muscarinic acetylcholine receptors in chick heart: influence of heat and N-ethylmaleimide on receptor conformations and interactions with guanine nucleotide-dependent regulatory proteins. Neurosci Lett (1985) 0.77
Protection afforded by clonidine from the acute and chronic behavioral toxicity produced by the cholinesterase inhibitor soman. Neurotoxicol Teratol (1989) 0.77
Fentanyl and sufentanil inhibit agonist binding to 5-HT1A receptors in membranes from the rat brain. Neuropharmacology (1991) 0.77
Colchicine inhibits acetylcholine receptor stimulation of G protein GTPase activity in rat striatum. Pharmacol Toxicol (1991) 0.77
Behavioral effects of toxic doses of soman, an organophosphate cholinesterase inhibitor, in the rat: protection afforded by clonidine. Pharmacol Biochem Behav (1988) 0.77
Volatile anesthetics and NMDA receptors. Enflurane inhibition of glutamate-stimulated [3H]MK-801 binding and reversal by glycine. Neurosci Lett (1991) 0.77
The influence of isoflurane on the synaptic activity of 5-hydroxytryptamine. Neurochem Res (1990) 0.77
Regulation of beta-adrenergic receptor density in the non-innervated and denervated embryonic chick heart. J Mol Cell Cardiol (1986) 0.77
Influence of acute and chronic ethanol treatment on muscarinic responses and receptor expression in Chinese hamster ovary cells. Biochem Pharmacol (1997) 0.76
Effect of pH on muscarinic acetylcholine receptors from rat brainstem. J Neurochem (1986) 0.76
Molecular mechanisms of the potent and stereospecific nicotinic receptor agonist (+)-anatoxin-a. Mol Pharmacol (1986) 0.76
Inhibition of endothelial-bound angiotensin converting enzyme, in vivo. Br J Pharmacol (1990) 0.75
Anatoxin-a interactions with cholinergic synaptic molecules. Proc Natl Acad Sci U S A (1981) 0.75
Role of phospholipids in muscarinic binding by neural membranes. Biochem Pharmacol (1977) 0.75
3-Chlorodibenzazepine binding to cholinergic receptors and ion channels. Res Commun Chem Pathol Pharmacol (1981) 0.75
Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. II. Enhancement of desensitization. Mol Pharmacol (1984) 0.75
Guanine nucleotide sensitivity of muscarinic acetylcholine receptors from rat brainstem is eliminated by endogenous proteolytic activity. Neurosci Lett (1984) 0.75
Diethyl ether effects on muscarinic acetylcholine receptor complexes in rat brainstem. Biochem Pharmacol (1988) 0.75
Calcium uptake by intestinal smooth muscle: influence of alkylation. Eur J Pharmacol (1983) 0.75
Levorphanol-sensitive [3H]naloxone binding in developing brainstem following prenatal morphine exposure. Neurosci Lett (1983) 0.75
Transition and heavy metal inhibition of ligand binding to muscarinic acetylcholine receptors from rat brain. Toxicol Appl Pharmacol (1979) 0.75
Detection and quantitation of fluorescamine-labeled bradykinin, its analogues and metabolites using high-performance liquid chromatography. J Chromatogr (1984) 0.75
Test-tube equilibration of volatile anaesthetic concentrations. Br J Anaesth (1993) 0.75
Halothane disruption of alpha 2-adrenergic receptor-mediated inhibition of adenylate cyclase and receptor G-protein coupling in rat brain. Biochem Pharmacol (1990) 0.75
Cholinergic actions of false neurotransmitters: acetylpyrrolidinecholine. Neurosci Lett (1981) 0.75
Receptor--ion channel interactions in Torpedo electric organ: influence of thiol group modification. Neurosci Lett (1982) 0.75
Cholinergic actions of false neurotransmitters: acetyldiethylcholine. Neurosci Lett (1982) 0.75
Atropine-induced alterations of normal development of muscarinic receptors in the embryonic chick heart. J Mol Cell Cardiol (1983) 0.75
Depressed growth of Morris hepatomas in altitude- and heat-stressed but not in cold-stressed buffalo rats. J Natl Cancer Inst (1980) 0.75